Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
PuraPharm Corp. Ltd. ( (HK:1498) ) has shared an update.
PuraPharm Corporation Limited has announced the appointment of Mr. Dong Zimeng as a non-executive director effective from October 30, 2025. Mr. Dong brings 17 years of experience in finance, capital market investment, mergers and acquisitions, and corporate operations. His expertise is expected to enhance PuraPharm’s strategic direction and operational efficiency, potentially impacting its market positioning positively. Mr. Dong’s appointment follows a nomination by Providence Discovery Fund, aligning with a subscription agreement that allows the fund to nominate a non-executive director.
The most recent analyst rating on (HK:1498) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on PuraPharm Corp. Ltd. stock, see the HK:1498 Stock Forecast page.
More about PuraPharm Corp. Ltd.
Average Trading Volume: 184,991
Technical Sentiment Signal: Sell
Current Market Cap: HK$163.9M
See more insights into 1498 stock on TipRanks’ Stock Analysis page.